CEL-SCI (CVM) announced that it intends to offer to sell shares of its common stock in a best efforts public offering. The company intends to use the net proceeds from this offering to fund the continued development of Multikine, for general corporate purposes, and working capital. ThinkEquity is acting as sole placement agent for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVM: